Insomnia
Conditions
Interventions
0.2% ropivacaine group:0.2% ropivacaine stellar ganglion block + cognitive behavioral therapy
0.8% lidocaine group:0.8% lidocaine stellar ganglion block + cognitive behavioral therapy
Sponsors
The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Age 18-75 years old, gender unlimited; 2.It meets the diagnostic criteria of chronic insomnia in the International Classification of Sleep Disorders; 3.Pittsburgh Sleep Quality Index (PSQI) score >=7; 4.Sign an informed consent form with the patient or his family;
Exclusion criteria
Exclusion criteria: 1.Those who are allergic to the drugs (lidocaine, ropivacaine); 2.Patients with consciousness disorder and cognitive dysfunction; 3.Severe heart block or cardiac insufficiency; 4.Abnormal coagulation function, puncture site infection; 5.Patients with other serious organic diseases;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index (PSQI); | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Health Questionnaire-9 (PHQ-9);Generalized Anxiety Disorder Scale (GAD-7);Psychomotor Alertness Test (PVT);Heart rate variability (HRV) test;Sleep diary;Satisfaction with sleep quality;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactWang Yongjia
The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed